NCT03422679 2024-01-16Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesCellestia Biotech AGPhase 1/2 Terminated79 enrolled 22 charts
NCT03886831 2023-03-28A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic MalignanciesPrelude TherapeuticsPhase 1 Completed232 enrolled
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled